MS drug
Betaseron® (interferon beta-1b) 250 mcg for SC injection
Company
Bayer Healthcare Pharmaceuticals, Inc.
Program description
The Betaseron Patient Assistance Program provides Betaseron to patients who meet program eligibility criteria and are otherwise unable to gain access to therapy.
Eligibility, exclusions, and limitations
Eligibility is based on household income, insurance status and patient residency. Patients will not qualify for the program if they exceed the financial eligibility guidelines, have adequate private insurance coverage or qualify for certain federal or state assistance program (e.g. Medicaid) for Betaseron, reside outside the US, or if they are not being treated by a U.S. physician.
Application process
There is a two-part application. Part one is for the patient or patient advocate to complete regarding patient demographic, insurance and income information. The patient also needs to submit proof of income. Part two is for the health care provider to complete regarding prescriber contact information and prescription. Once the completed forms are received, the application is reviewed, and the patient and provider are notified of a decision within two business days.
More information
Applications may be downloaded at www.needymeds.com
MS drug
Avonex® and Tysabri®
Company
Biogen Idec
Program description
Biogen Idec offers numerous patient assistance programs for new and existing patients. Patient assistance services can range from: co-pay assistance, alternative funding to assist with the cost of therapy and free drug programs.
The Access Program is one of several Biogen Idec patient assistance programs. This program is tailored to address the various needs of patients based on their insurance and financial circumstances.
Additionally, a patient may be referred to an alternative funding source for assistance. Biogen Idec partners will investigate the benefit structure of the patient's insurance plan and will research ways a patient can maximize coverage. They also look into supplemental sources of coverage and funding for treatment, if required. Learn more about all of Biogen Idec's financial assistance options by calling us at 1-800-456-2255.
Eligibility, exclusions, and limitations
Patients must be using Avonex or Tysabri on-label indication and be a U.S. resident. Biogen Idec is committed to working with patients with a range of needs and finding optimal solutions.
Application process
Patients should call Biogen Idec at 1-800-456-2255, Monday-Friday, 8:30am-8:00pm ET to explore speak live with a member of the Biogen Idec Patient Services team.
More information
Website link for additional information and application:
www.AVONEX.com
www.TYSABRI.com
MS drug
Rebif® (interferon beta-1a)
Company
EMD Serono, Inc. and Pfizer Inc
Program description
The MS LifeLines Access Made Simple Program provides simplified and affordable access to therapy for people with relapsing forms of MS. The program is available to U.S. patients who have either been newly prescribed Rebif by their physician or who have restarted Rebif therapy after having discontinued it for more than 90 days. All eligible participants will receive up to one year of therapy regardless of income level, with no more than a $50 co-payment per month required of any patient.
Eligibility, exclusions, and limitations
Patients with relapsing forms of MS who have either been newly prescribed Rebif or who have restarted Rebif therapy after having previously discontinued Rebif for at least 90 days are eligible. This program is only available to patients who are U.S. residents. Patients enrolled in a Medicare Part D plan are not eligible; they may apply for financial assistance via the MS LifeLines Medicare Part D Patient Assistance Program. Patients residing in certain states, as well as patients covered by federal and state healthcare programs, also may not be eligible.
Application process
There is no enrollment process; patients are automatically enrolled when they follow standard procedures already in place for voluntary enrollment in MS LifeLines support services.
More information
Please visit www.mslifellines.com or call 1-877-44-REBIF (1-877-447-3243).
MS Drug
Copaxone®
Company
Teva Neuroscience
Program description
A copay assistance program is available through Shared Solutions for those who qualify. There is also assistance for Medicare Part D and free product for those who qualify.
Eligibility, exclusions, and limitations
For the Private Copay Program the patient must not receive coverage from any federal or state government assistance program, including but not limited to Medicare, Medicaid, TRICARE or a PACE program. There are also a few states that prohibit us from providing assistance to their residents.
Application process
An application will need to be completed and if you have insurance please have that information readily available.
More information
Call Shared Solutions at 1-800-887-8100. You will be put in touch with a benefits investigator.